LinkResPet’s products consist of CBD tinctures for dogs and cats. While DailyLifeCBD has a functional mushroom and CBD range of products including its DailyLifeCBD Immune tincture, as well as other CBD products in the pipeline. All products are made with the highest quality hemp oil and are lab tested, THC and GMO free. The hemp oil used in LRSV products comes from organically grown certified
For more information about LinkResPet or to purchase CBD products for pets, please visit www.linkrespet.com or follow us on Twitter @res_pet
For more information about DailyLifeCBD, the Company’s range of CBD and mushroom product for people, please visit: https://dailylifecbd.com/
About
Forward-Looking Statements & Disclaimers:
The information in this Press Release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws, as that term is defined in section 27a of the United States Securities Act of 1933, as amended, and section 21e of the United States Securities Exchange Act of 1934, as amended. Statements in this document, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.
Reading
Phone: +44 330 808 0897
Source:
2021 GlobeNewswire, Inc., source